Orphenadrine Recalled Due to Possible Nitrosamine Impurity

The voluntary recall of Orphenadrine Citrate 100 mg Extended Release Tablets by Sandoz involves 13 lots of the drug that were shipped to consumers from August 2019 to April 2021.
Medscape Medical News